Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02613260 · ClinicalTrials.gov registry record · NA
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
A NA study of Colonic Neoplasms, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 13,470
- Enrollment target
- 1
- Study location
NCT02613260: Completed NA study of Colonic Neoplasms, sponsored by University of California, San Francisco.
NCT02613260 is a NA study of Colonic Neoplasms that has completed, run by University of California, San Francisco. The registered enrollment target is 13,470 participants, above the 561-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (2301% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02613260, a NA study of Colonic Neoplasms, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 13,470 participants
- Enrollment target
- 1
- Study location
Study Summary
Uptake of colorectal cancer (CRC) screening is suboptimal in the San Francisco Health Network and access to care may be limited so novel models of health care delivery are warranted. The objective of this study is to examine whether a centralized panel management model with mailed fecal immunochemical test (FIT) will be effective at increasing the uptake of CRC screening and could be developed and sustained within the typical parameters of cost-effectiveness and budget impact analyses.
Primary Outcome
The primary outcome is the completion rate for CRC screening one-year after randomization between mailed FIT outreach and usual care.
Conditions Studied
Interventions
- BEHAVIORAL FIT Outreach
Study Locations (1)
California
- University of California, San Francisco-San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,470 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2019-01-01 |
| Phase | NA |
What the finished NCT02613260 record still lists
NCT02613260 is an interventional study that assigns participants to a tested intervention. Its 13,470 participants enrollment target places it among the larger protocols in the corpus, above the 561-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (2301% higher).
The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which FIT Outreach is the first listed.
NCT02613260 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02613260 about?
NCT02613260 is a clinical study titled "Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System". Uptake of colorectal cancer (CRC) screening is suboptimal in the San Francisco Health Network and access to care may be limited so novel models of health care delivery are warranted. The objective of this study is to examine whether a centralized panel management model with mailed fecal immunochemic...
What is the current status of trial NCT02613260?
This trial is currently completed. It is a NA study. The enrollment target is 13,470 participants. The study started on 2016-01-01. Estimated completion is 2019-01-01.
What conditions does trial NCT02613260 study?
This clinical trial studies the following conditions: Colonic Neoplasms.
What interventions are being tested in trial NCT02613260?
The interventions under investigation include: FIT Outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT02613260?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02613260 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02613260's enrollment target sits among peer trials
13,470 1st of 14 higher than 14 of 14 other Colonic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strategies for Optimizing a Mailed FIT Program in Appalachia
RECRUITING · NA
-
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
RECRUITING · NA
-
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
RECRUITING · NA
-
Japanese National Computed Tomographic (CT) Colonography Trial
COMPLETED · NA
-
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
COMPLETED · NA
-
Case Series With Saneso 3600 Colonoscope
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI